TGFβ as a tumor promoterdetermines mesenchymal-epithelial transition (MET), increases the activity ofproteases, decreases immune response, promotes angiogenesis, and modulates thecytoskeletal architecture and extracellular matrix (Padua and Massagué, 2009; Yanget al., 2010; Heldinet al., 2012). Here, TGFB1 is linked to neoplasm.